Your session is about to expire
← Back to Search
Azstarys for ADHD
Study Summary
This trial will look at how Azstarys affects adults with ADHD in terms of symptoms, Executive Function, and safety.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2011 Phase 4 trial • 212 Patients • NCT00429273Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has the FDA verified the use of medications for treating Adult ADHD?
"Adult ADHD patients have a safety score of 3, since this is a Phase 4 clinical trial and the treatment has already received approval."
Is recruitment for this research endeavor still taking place?
"All evidence points to this clinical trial still needing enrollees. The experiment was initially posted on September 14th 2023 and has since been revised most recently on the 15th of same month."
Is this clinical trial open to participants aged thirty and above?
"This research effort is open to adults aged 18-60. Kindly note that there are 90 studies available for minors and 30 clinical trials specifically designed for seniors over 65 years old."
How many volunteers are involved in this experiment?
"Affirmative. Clinicaltrials.gov shows that this clinical trial, initiated on September 14th 2023, is seeking out suitable applicants. 30 individuals are being recruited from a single medical centre."
Who is the ideal candidate to partake in this research endeavor?
"The prerequisites for this clinical trial involve having a diagnosis of ADHD, and being between the ages 18 to 60. Currently, 30 individuals are eligible to partake in this research."
What goals is the research hoping to realize?
"As measured at both Baseline and Week 2, the primary aim of this trial is to determine Change in Expanded AISRS Score. Secondary outcomes that will be tracked include Change in Expanded AISRS - Hyperactive/Impulsive (HI) Subscale Score, 1-Hour Post-Dose TASS Score at Visit 3, and 1-Hour Post-Dose TASS Score at Visit 4; all three parameters are rated on a four point Likert scale ranging from 0 (none) to 3 (severe)."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger